X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

DALS

Closed

Da32 Life Science Tech Acquisition Corp

10.32
0.00 (0.00%)
Last Update: 04 Aug 2023 16:30:00
Yesterday: 10.32
Day's Range: 10.32 - 10.32
Send
When Written:
 
10.12
Da32 Life Science Tech Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021 with the aim of acquiring and merging with a target company in the life science and technology sectors. The company is led by CEO David Nassif and Chairman Dr. Mark Goldberger, both of whom have extensive experience in the healthcare and life science industries.

Da32 Life Science Tech Acquisition Corp raised $100 million in its initial public offering (IPO) in February 2021 and is listed on the NASDAQ under the ticker symbol "DALSU". The company has stated that it is focused on identifying and acquiring companies that are developing innovative technologies and solutions in areas such as biotechnology, medical devices, diagnostics, and digital health.

As a SPAC, Da32 Life Science Tech Acquisition Corp has a limited lifespan and must complete its acquisition within a set timeframe or return the funds raised to its investors. The company has not yet announced any potential acquisition targets.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X